• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性鼻泪管阻塞患儿原发性单通道支架置入的结果。

Outcome of Primary Monocanalicular Stent Placement in Pediatric Down Syndrome Patients with Congenital Nasolacrimal Obstruction.

机构信息

The Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.

Division of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Sheba.

出版信息

Ophthalmic Plast Reconstr Surg. 2023;39(6):579-582. doi: 10.1097/IOP.0000000000002406. Epub 2023 May 2.

DOI:10.1097/IOP.0000000000002406
PMID:37133389
Abstract

PURPOSE

Congenital Nasolacrimal duct obstruction (CNLDO) is a relatively common problem in children with Down syndrome (DS). Probing and irrigation (PI) with monocanalicular stent intubation may be less successful than in non-DS patients, thus raising some concerns regarding the preferred treatment in this population. We aimed to analyze the surgical outcome of PI along with monocanalicular stent intubation in children with DS compared with non-DS patients.

METHODS

Retrospective cohort study. Thirty-five eyes of 19 children with DS and 1,472 eyes of 1,001 children without DS underwent PI-monocanalicular stent intubation as a primary treatment for CNLDO. All patients were operated on by a single surgeon at the Children's Hospital of Philadelphia between 2009 and 2020. The main outcome measure was a surgical success, defined as the resolution of symptoms after surgery.

RESULTS

A total of 1,020 patients were included, 48% females; mean age of 1.9 ± 1.4 years. The mean follow-up time was 35.0 months. The DS patients group consisted of 19 patients. Higher rates of right nasolacrimal duct obstruction and bilateral obstructions were observed in the DS group (100% vs. 73.2%; p = 0.006, and 84.2% vs. 46.8%; p = 0.001, respectively). Patients with DS had a lower success rate (57.1% vs. 92.4%; p < 0 .0001). The median time to failure was 3.1 months in the DS group, and 5.2 months in the group of patients without DS. The hazard ratio comparing DS to the no-DS outcome was 6.6 (95% CI: 3.2-13.7; p < 0.001).

CONCLUSIONS

CNLDO in DS is more likely to be bilateral and less likely to resolve after primary monocanalicular stent placement.

摘要

目的

先天性鼻泪管阻塞(CNLDO)在唐氏综合征(DS)患儿中较为常见。与非 DS 患者相比,使用单通道探通联合支架植入术的效果可能较差,因此对于该人群的首选治疗方法存在一些担忧。我们旨在分析 DS 患儿与非 DS 患儿接受探通联合单通道支架植入术的手术效果。

方法

回顾性队列研究。2009 年至 2020 年,在费城儿童医院,由同一位外科医生对 19 例患儿的 35 只眼和 1001 例患儿的 1472 只眼进行了 PI-单通道支架植入术作为 CNLDO 的一线治疗。主要观察指标为手术成功率,定义为手术后症状缓解。

结果

共纳入 1020 例患者,女性占 48%;平均年龄 1.9±1.4 岁。平均随访时间为 35.0 个月。DS 患儿组包括 19 例患者。DS 组中右鼻泪管阻塞和双侧阻塞的发生率较高(100%比 73.2%,p=0.006 和 84.2%比 46.8%,p=0.001)。DS 患儿的成功率较低(57.1%比 92.4%,p<0.0001)。DS 组的中位失败时间为 3.1 个月,无 DS 组为 5.2 个月。DS 组与无 DS 组的风险比为 6.6(95%可信区间:3.2-13.7;p<0.001)。

结论

DS 中的 CNLDO 更可能是双侧的,并且在初次单通道支架植入后不太可能缓解。

相似文献

1
Outcome of Primary Monocanalicular Stent Placement in Pediatric Down Syndrome Patients with Congenital Nasolacrimal Obstruction.先天性鼻泪管阻塞患儿原发性单通道支架置入的结果。
Ophthalmic Plast Reconstr Surg. 2023;39(6):579-582. doi: 10.1097/IOP.0000000000002406. Epub 2023 May 2.
2
Probing for congenital nasolacrimal duct obstruction.探查先天性鼻泪管阻塞
Cochrane Database Syst Rev. 2017 Jul 12;7(7):CD011109. doi: 10.1002/14651858.CD011109.pub2.
3
Assessing the success rate of treatment in simple and complex congenital nasolacrimal duct obstruction: a systematic review and meta-analysis.评估单纯型和复杂型先天性鼻泪管阻塞治疗成功率:系统评价和荟萃分析。
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):1993-2004. doi: 10.1007/s00417-023-06318-4. Epub 2023 Dec 7.
4
Primary Monocanalicular Stent Intubation for Children With Congenital Nasolacrimal Duct Obstruction: Surgical Outcome and Risk Factors.儿童先天性鼻泪管阻塞的单通道支架插管:手术结果和危险因素。
Ophthalmic Plast Reconstr Surg. 2022;38(5):490-495. doi: 10.1097/IOP.0000000000002182. Epub 2022 May 3.
5
Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction.鼻内与外部泪囊鼻腔造口术治疗鼻泪管阻塞
Cochrane Database Syst Rev. 2017 Feb 24;2(2):CD007097. doi: 10.1002/14651858.CD007097.pub3.
6
Association between congenital nasolacrimal duct obstruction and otitis media.先天性鼻泪管阻塞与中耳炎之间的关联。
J AAPOS. 2025 Jun;29(3):104211. doi: 10.1016/j.jaapos.2025.104211. Epub 2025 May 9.
7
Probing for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis of randomized clinical trials.探讨先天性鼻泪管阻塞的方法:一项随机临床试验的系统评价和荟萃分析。
Arq Bras Oftalmol. 2021 Jan-Feb;84(1):91-98. doi: 10.5935/0004-2749.20210005.
8
Management of congenital nasolacrimal duct obstruction in down syndrome.唐氏综合征患儿先天性鼻泪管阻塞的管理。
Eye (Lond). 2023 Mar;37(4):739-743. doi: 10.1038/s41433-022-02047-w. Epub 2022 Apr 4.
9
Comparison of treatment for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis.先天性鼻泪管阻塞的治疗比较:一项系统评价和荟萃分析
Can J Ophthalmol. 2016 Feb;51(1):34-40. doi: 10.1016/j.jcjo.2015.10.002.
10
Surgical interventions for bilateral congenital cataract in children aged two years and under.儿童两岁及以下双侧先天性白内障的手术干预。
Cochrane Database Syst Rev. 2022 Sep 15;9(9):CD003171. doi: 10.1002/14651858.CD003171.pub3.